Antiplatelet Therapy in Cardiovascular Disease
Publication
, Book
Waksman, R; Gurbel, PA; Gaglia, MA
June 3, 2014
Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells. Thoroughly covers platelet function testing, including novel techniques. Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease. Reviews all types of antiplatelet agents - from aspirin to recently approved drugs - including indications, clinical outcomes, and side effects.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Waksman, R., Gurbel, P. A., & Gaglia, M. A. (2014). Antiplatelet Therapy in Cardiovascular Disease (pp. 1–325). https://doi.org/10.1002/9781118493984
Waksman, R., P. A. Gurbel, and M. A. Gaglia. Antiplatelet Therapy in Cardiovascular Disease, 2014. https://doi.org/10.1002/9781118493984.
Waksman R, Gurbel PA, Gaglia MA. Antiplatelet Therapy in Cardiovascular Disease. 2014.
Waksman, R., et al. Antiplatelet Therapy in Cardiovascular Disease. 2014, pp. 1–325. Scopus, doi:10.1002/9781118493984.
Waksman R, Gurbel PA, Gaglia MA. Antiplatelet Therapy in Cardiovascular Disease. 2014. p. 1–325.